Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A11 | P48066 | 8/20 | 0.52 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.52 |
| ▸ | SLC6A12 | P48065 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.48 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10118446 | 0.88 | SLC6A11 (0.55) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL19463293 | 0.86 | SLC6A11 (0.46) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL26502803 | 0.83 | SLC6A11 (0.52) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL15592424 | 0.82 | SLC6A11 (0.45) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL16392604 | 0.81 | DPP4 (0.45) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL16392603 | 0.81 | SLC6A11 (0.48) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL18413370 | 0.81 | SLC6A11 (0.48) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL10118380 | 0.81 | SLC6A11 (0.48) | SLC6A11SLC6A1SLC6A12MEN1TP53 | |
| SCHEMBL15525872 | 0.79 | SLC6A1 (0.49) | SLC6A11SLC6A1MEN1CYP3A4KMT2A | |
| SCHEMBL16357997 | 0.79 | SLC6A11 (0.47) | SLC6A11SLC6A1SLC6A12MEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160108400-A1 | Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression | BONAC CORPORATION (JP) | 2016-04-21 | — | — | US | disclosed |
| US-9206422-B2 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORPORATION (JP) | 2015-12-08 | — | — | US | disclosed |
| US-9200278-B2 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORPORATION (JP) | 2015-12-01 | — | — | US | disclosed |
| EP-2933333-A1 | SINGLE-STRAND NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION | Bonac Corporation (JP) | 2015-10-21 | — | — | EP | disclosed |
| EP-2639307-B1 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORP (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-20150011605-A1 | Single-Stranded Nucleic Acid Molecule for Controlling Gene Expression | BONAC CORPORATION (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2628801-B1 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORP (JP) | 2015-01-07 | — | — | EP | disclosed |
| US-8785121-B2 | Single-stranded nucleic acid molecule for controlling gene expression | BONAC CORPORATION (JP) | 2014-07-22 | — | — | US | disclosed |
| US-20140171486-A1 | Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton | BONAC CORPORATION (JP) | 2014-06-19 | — | — | US | disclosed |
| US-20140171633-A1 | Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton | BONAC CORPORATION (JP) | 2014-06-19 | — | — | US | disclosed |
| US-8691782-B2 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | BONAC CORPORATION (JP) | 2014-04-08 | — | — | US | disclosed |
| EP-2639307-A2 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | Bonac Corporation (JP) | 2013-09-18 | — | — | EP | disclosed |
| EP-2628801-A1 | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton | Bonac Corporation (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-2431466-A1 | SINGLE-STRAND NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION | Bonac Corporation (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120035246-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING NITROGEN-CONTAINING ALICYCLIC SKELETON | BONAC CORPORATION (JP) | 2012-02-09 | — | — | US | disclosed |
| US-20120010271-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION | BONAC CORPORATION (JP) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010271-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE FOR CONTROLLING GENE EXPRESSION | SRRT, SSU72, RPRD2 | SLC6A11 2828/4885SLC6A1 2904/4885SLC6A12 3269/4885 |
| US-20140171633-A1 | Single-Stranded Nucleic Acid Molecule Having Nitrogen-Containing Alicyclic Skeleton | NSUN2, CTDSP1, RNGTT | SLC6A11 4043/4885SLC6A1 3932/4885SLC6A12 3999/4885 |
| US-20120035246-A1 | SINGLE-STRANDED NUCLEIC ACID MOLECULE HAVING NITROGEN-CONTAINING ALICYCLIC SKELETON | NSUN2, CTDSP1, RNGTT | SLC6A11 4043/4885SLC6A1 3932/4885SLC6A12 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.